News
15 November, 2021 - 02:00 (CET)
Announcement
M
Molnupiravir 200 mg capsules for oral administration invited for COVID-19.
For further details see 5th Invitation to Manufacturers of therapeutics against COVID-19 to submit an Expression of Interest (EOI).